CSRxP Applauds Grassley, Wyden for Moving Ahead on Drug Pricing Package

Looks Forward to Working With Senate Finance Members to Hold Big Pharma Accountable 

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday commending Chairman Chuck Grassley (R-IA) and Ranking Member Ron Wyden (D-OR) for moving ahead with a U.S. Senate Committee on Finance package to lower prescription drug prices. On Tuesday, Grassley noticed a legislative markup on the package will take place Thursday.

“We applaud Chairman Grassley and Ranking Member Wyden for their dedication to lowering prescription drug prices for Americans,” said CSRxP executive director Lauren Aronson. “The committee’s bipartisan actions are a good first step. We are reviewing the details of this package and look forward to working with committee members to advance measures to hold Big Pharma accountable.”

Read more on market-based solutions to lower prescription drug prices HERE.